Looking at the demand for put over call options, fear remains at extreme levels despite the 90-day delay in most tariffs, say strategists led by John Marshall, head of derivatives research at Goldman Sachs.
America’s generic-drug crisis can be fixed in two words: pharma tariffs
Strong U.S. production isn’t just good economic policy; it’s about national security and public health.
